• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为HIV-1蛋白酶抑制剂的色酮衍生物的3D-QSAR研究:分子场分析的应用

3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: application of molecular field analysis.

作者信息

Nunthanavanit Patcharawee, Anthony Nahoum G, Johnston Blair F, Mackay Simon P, Ungwitayatorn Jiraporn

机构信息

Faculty of Pharmacy, Srinakharinwirot University, Nakhon Nayok, Thailand.

出版信息

Arch Pharm (Weinheim). 2008 Jun;341(6):357-64. doi: 10.1002/ardp.200700229.

DOI:10.1002/ardp.200700229
PMID:18442018
Abstract

Three-dimensional quantitative structure-activity relationship (3D-QSAR) models were developed for chromone derivatives against HIV-1 protease using molecular field analysis (MFA) with genetic partial least square algorithms (G/PLS). Three different alignment methods: field fit, pharmacophore-based, and receptor-based were used to derive three MFA models. All models produced good predictive ability with high cross-validated r(2) (r(2) (cv)), conventional r(2), and predictive r(2)(r(2)(pred)) values. The receptor-based MFA showed the best statistical results with r(2) (cv) = 0.789, r(2)= 0.886, and r(2)(pred) = 0.995. The result obtained from the receptor-based model was compared with the docking simulation of the most active compound 21 in this chromone series to the binding pocket of HIV-1 protease (PDB entry 1AJX). It was shown that the MFA model related well with the binding structure of the complex and can provide guidelines to design more potent HIV-1 protease inhibitors.

摘要

使用遗传偏最小二乘算法(G/PLS)的分子场分析(MFA),针对色酮衍生物抗HIV-1蛋白酶构建了三维定量构效关系(3D-QSAR)模型。采用三种不同的比对方法:场拟合、基于药效团和基于受体,推导得到三个MFA模型。所有模型均具有良好的预测能力,具有较高的交叉验证r(2)(r(2) (cv))、常规r(2)和预测r(2)(r(2)(pred))值。基于受体的MFA显示出最佳的统计结果,r(2) (cv) = 0.789,r(2)= 0.886,r(2)(pred) = 0.995。将基于受体模型得到的结果与该色酮系列中活性最高的化合物21与HIV-1蛋白酶结合口袋(PDB编号1AJX)的对接模拟结果进行比较。结果表明,MFA模型与复合物的结合结构相关性良好,可为设计更有效的HIV-1蛋白酶抑制剂提供指导。

相似文献

1
3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: application of molecular field analysis.作为HIV-1蛋白酶抑制剂的色酮衍生物的3D-QSAR研究:分子场分析的应用
Arch Pharm (Weinheim). 2008 Jun;341(6):357-64. doi: 10.1002/ardp.200700229.
2
Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.新型富勒烯类似物作为潜在HIV-1蛋白酶抑制剂的计算设计:使用三维定量构效关系、分子对接和分子动力学模拟分析富勒烯抑制剂与HIV-1蛋白酶残基之间的结合相互作用。
Bioorg Med Chem. 2008 Dec 1;16(23):9957-74. doi: 10.1016/j.bmc.2008.10.039. Epub 2008 Oct 22.
3
3D-QSAR CoMFA/CoMSIA models based on theoretical active conformers of HOE/BAY-793 analogs derived from HIV-1 protease inhibitor complexes.基于从 HIV-1 蛋白酶抑制剂复合物中得出的 HOE/BAY-793 类似物的理论活性构象的 3D-QSAR CoMFA/CoMSIA 模型。
Eur J Med Chem. 2009 Nov;44(11):4344-52. doi: 10.1016/j.ejmech.2009.05.016. Epub 2009 May 23.
4
Three-dimensional quantitative structure-activity relationship (3 D-QSAR) and docking studies on (benzothiazole-2-yl) acetonitrile derivatives as c-Jun N-terminal kinase-3 (JNK3) inhibitors.作为c-Jun氨基末端激酶-3(JNK3)抑制剂的(苯并噻唑-2-基)乙腈衍生物的三维定量构效关系(3D-QSAR)及对接研究
Bioorg Med Chem Lett. 2006 Nov 15;16(22):5917-25. doi: 10.1016/j.bmcl.2006.06.039. Epub 2006 Sep 20.
5
Structure-based QSAR analysis of a set of 4-hydroxy-5,6-dihydropyrones as inhibitors of HIV-1 protease: an application of the receptor-dependent (RD) 4D-QSAR formalism.基于结构的一组4-羟基-5,6-二氢吡喃酮作为HIV-1蛋白酶抑制剂的定量构效关系分析:受体依赖性(RD)4D-定量构效关系形式主义的应用
J Chem Inf Model. 2006 Jan-Feb;46(1):345-54. doi: 10.1021/ci050326x.
6
3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods.基于不同比对方法的抗结核胸苷单磷酸激酶抑制剂的3D-QSAR研究
Bioorg Med Chem Lett. 2006 Feb 15;16(4):1014-20. doi: 10.1016/j.bmcl.2005.10.086. Epub 2005 Nov 15.
7
Exploring QSARs for inhibitory activity of non-peptide HIV-1 protease inhibitors by GA-PLS and GA-SVM.应用遗传算法偏最小二乘法和遗传算法支持向量机研究非肽类 HIV-1 蛋白酶抑制剂的抑制活性的定量构效关系。
Chem Biol Drug Des. 2010 May;75(5):506-14. doi: 10.1111/j.1747-0285.2010.00953.x.
8
3D-QSAR of human immunodeficiency virus (I) protease inhibitors. III. Interpretation of CoMFA results.人类免疫缺陷病毒(I)蛋白酶抑制剂的3D-QSAR。III. CoMFA结果解读。
Drug Des Discov. 1994 Jul;12(1):29-51.
9
3D-QSAR studies of triazafluorenone inhibitors of metabotropic glutamate receptor subtype 1.代谢型谷氨酸受体亚型1的三氮杂芴酮抑制剂的3D-QSAR研究
Eur J Med Chem. 2008 May;43(5):1025-34. doi: 10.1016/j.ejmech.2007.06.024. Epub 2007 Jul 14.
10
Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: application of comparative molecular field analysis.作为HIV-1蛋白酶抑制剂的环脲衍生物的三维定量构效关系研究:比较分子场分析的应用
J Med Chem. 1999 Jan 28;42(2):249-59. doi: 10.1021/jm980369n.

引用本文的文献

1
Recent advances in fragment-based QSAR and multi-dimensional QSAR methods.基于片段的定量构效关系和多维定量构效关系方法的最新进展。
Int J Mol Sci. 2010 Oct 8;11(10):3846-66. doi: 10.3390/ijms11103846.
2
Current mathematical methods used in QSAR/QSPR studies.当前在定量构效关系(QSAR)/定量构性关系(QSPR)研究中使用的数学方法。
Int J Mol Sci. 2009 Apr 29;10(5):1978-1998. doi: 10.3390/ijms10051978.